Business Context and Reporting Period
Company: Village Farms International, Inc. (VFF)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: VFF operates primarily in the cannabis sector through subsidiaries Pure Sunfarms (Canada), Balanced Health (U.S. CBD), and VFN (Netherlands). The company recently reorganized its reporting structure into a single "Cannabis" segment, with remaining operations (Produce and Clean Energy) classified as "Other." The Produce segment was privatized in May 2025 and is now reported as discontinued operations.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $50.2 million | $39.7 million |
| Gross Profit | $21.0 million | $14.2 million |
| Gross Margin | 41.8% | 35.7% |
| Net Income (Attributable to Shareholders) | $2.9 million | ($6.7 million) Loss |
| Adjusted EBITDA (Continuing Ops) | $9.9 million | $4.5 million |
| Cash and Cash Equivalents | $50.5 million | $15.1 million (End of Q1 2025) |
| Total Debt (Long-term + Current) | $35.7 million | $33.7 million (Dec 31, 2025) |
| Working Capital | $88.8 million | $95.9 million (Dec 31, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 27% year-over-year, driven primarily by a 171% surge in International Exports ($14.6 million), which now represent 29% of total revenue.
- Profitability Turnaround: The company returned to profitability with $2.9 million in net income, compared to a $6.7 million loss in Q1 2025. This improvement excludes the $5.0 million loss from discontinued operations recorded in the prior year.
- Margin Expansion: Gross margin improved to 41.8% from 35.7%, aided by a favorable shift in export sales mix toward bulk flower and higher volumes.
- Cash Flow: Operating cash flow was negative $16.8 million, a significant increase in usage compared to the prior year, largely due to $15.1 million in income tax payments.
- Capital Allocation: The company repurchased 2.06 million shares for $6.4 million during the quarter.
Guidance, Outlook, and Risks
- Operational Outlook: Management expects the Netherlands Phase II facility to ramp to full capacity by end of 2026, potentially quintupling production. The Delta 2 greenhouse expansion in Canada is underway, expected to add 40 metric tonnes of annual capacity by 2027.
- Regulatory Catalyst: On April 23, 2026, President Trump issued an executive order to reschedule marijuana to Schedule III, with an expedited hearing process expected to commence June 29, 2026. Management views this as a positive catalyst for U.S. operations.
- Debt Management: The company successfully amended its Farm Credit Canada (FCC) Term Loan, extending maturity to 2031 and reducing the interest margin by 50 basis points. It also increased commitments on its Pure Sunfarms credit facility by C$15 million.
- Risks: Key risks include regulatory uncertainty in the U.S. and Canada, foreign exchange exposure (CAD/USD), reliance on credit facilities, and the integration of recent acquisitions. The company maintains a valuation allowance on deferred tax assets due to uncertainty regarding future taxable income.
Investor Verification Checklist
- Export Sustainability: Verify the durability of the 171% growth in international exports and the specific contract terms with European distributors.
- Cash Burn vs. Liquidity: Assess the impact of the $16.8 million operating cash outflow on the $50.5 million cash balance and the sufficiency of liquidity for the next 12 months.
- Debt Covenants: Confirm ongoing compliance with financial covenants under the FCC and Pure Sunfarms credit facilities, particularly given the recent debt amendments.
- Regulatory Timeline: Monitor the progress of the U.S. Schedule III rescheduling process and its tangible impact on the U.S. CBD/Cannabis segment.
- Share Repurchase Impact: Evaluate the remaining $0.7 million authorization under the share buyback program and the strategic rationale for repurchases amidst capital expenditure needs.